John Vavricka - Chief Commercial Officer at Atea Pharmaceuticals, Inc.
Insider Transactions and Holdings
- Entity Type
- Individual
- Role
- Chief Commercial Officer
- Issuer Symbol
- AVIR on Nasdaq
- All Insider Reports
- All Insider Reports
There are no Buy or Sell transactions made by John Vavricka since 05 Apr 2025
Holdings reported by John Vavricka for Atea Pharmaceuticals, Inc.
| Security | Num Shares | Value | Price $ | Transaction Date | Ownership | Underlying Class | Underlying Amount |
|---|---|---|---|---|---|---|---|
| Common Stock | 82,594 | $350,198 | $4.24 | 31 Jan 2026 | Direct | ||
| Common Stock | 82,508 | $294,553 | $3.57 | 31 Jan 2026 | Held by John Vavricka as the Trustee of the John F. Vavricka Deed of Trust | ||
| Restricted Stock Units | 0 | $26,775 | $3.06 | 31 Jan 2026 | Direct | Common Stock | |
| Stock Option (Right to Buy) | 119,520 | 31 Jan 2026 | Direct | Common Stock |
Transactions reported by John Vavricka for Atea Pharmaceuticals, Inc.
| Sym | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
|---|
* An asterisk sign (*) next to the price indicates that the price is likely invalid.